In addition to IL27, IL10 also negatively affects proangiogenic cells in the tumor microenvironment, such as activated macrophages, by inhibiting proangiogenic MMP2 and upregulating TIMP 1 and thereby suppressing the process of angiogenesis during PCa progression [95]. The gene discussed is MMP2; the disease is neoplasm.